These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 30080906)

  • 1. Tear biomarkers in latanoprost and bimatoprost treated eyes.
    Reddy S; Sahay P; Padhy D; Sarangi S; Suar M; Modak R; Rao A
    PLoS One; 2018; 13(8):e0201740. PubMed ID: 30080906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ocular Surface Disease in Glaucoma Patients Randomized to Benzalkonium Chloride-Containing Latanoprost and Preservative-Free Bimatoprost.
    Wu JH; Wang TH; Huang JY; Su CC
    J Ocul Pharmacol Ther; 2021 Dec; 37(10):556-564. PubMed ID: 34610257
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of latanoprost on the expression of matrix metalloproteinases and tissue inhibitor of metalloproteinase 1 on the ocular surface.
    Honda N; Miyai T; Nejima R; Miyata K; Mimura T; Usui T; Aihara M; Araie M; Amano S
    Arch Ophthalmol; 2010 Apr; 128(4):466-71. PubMed ID: 20385943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of prostaglandin analogs: Latanoprost, bimatoprost, and unoprostone on matrix metalloproteinases and their inhibitors in human trabecular meshwork endothelial cells.
    Heo JY; Ooi YH; Rhee DJ
    Exp Eye Res; 2020 May; 194():108019. PubMed ID: 32222455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostaglandin agonist effect on matrix metalloproteinase aqueous levels in glaucoma patients.
    Pradhan ZS; Dalvi RA; Lai T; Kranemann C; Boyd S; Birt CM
    Can J Ophthalmol; 2015 Feb; 50(1):6-10. PubMed ID: 25677276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ocular surface tolerability of prostaglandin analogs in patients with glaucoma or ocular hypertension.
    Whitson JT; Trattler WB; Matossian C; Williams J; Hollander DA
    J Ocul Pharmacol Ther; 2010 Jun; 26(3):287-92. PubMed ID: 20578283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tolerability and efficacy of bimatoprost 0.01 % in patients with open-angle glaucoma or ocular hypertension evaluated in the Taiwanese clinical setting: the Asia Pacific Patterns from Early Access of Lumigan 0.01 % (APPEAL Taiwan) study.
    Chen YY; Wang TH; Liu C; Wu KY; Chiu SL; Simonyi S; Lu DW
    BMC Ophthalmol; 2016 Sep; 16(1):162. PubMed ID: 27633513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of bimatoprost, latanoprost, and unoprostone on matrix metalloproteinases and their inhibitors in human ciliary body smooth muscle cells.
    Ooi YH; Oh DJ; Rhee DJ
    Invest Ophthalmol Vis Sci; 2009 Nov; 50(11):5259-65. PubMed ID: 19443729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Effect of Prostaglandin Analogues on the Ciliary Zonular Fibers of the Rabbit Crystalline Lens.
    Hwang HB; Kim SY
    Curr Eye Res; 2018 Nov; 43(11):1357-1361. PubMed ID: 30015523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of bimatoprost on patients with primary open-angle glaucoma or ocular hypertension who are nonresponders to latanoprost.
    Gandolfi SA; Cimino L
    Ophthalmology; 2003 Mar; 110(3):609-14. PubMed ID: 12623831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood-aqueous barrier changes after the use of prostaglandin analogues in patients with pseudophakia and aphakia: a 6-month randomized trial.
    Arcieri ES; Santana A; Rocha FN; Guapo GL; Costa VP
    Arch Ophthalmol; 2005 Feb; 123(2):186-92. PubMed ID: 15710814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional Activity of Matrix Metalloproteinases 2 and 9 in Tears of Patients With Glaucoma.
    Sahay P; Rao A; Padhy D; Sarangi S; Das G; Reddy MM; Modak R
    Invest Ophthalmol Vis Sci; 2017 May; 58(6):BIO106-BIO113. PubMed ID: 28586796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-offset analysis: bimatoprost versus other prostaglandin analogues in open-angle glaucoma.
    Berenson KL; Kymes S; Hollander DA; Fiscella R; Burk C; Patel VD
    Am J Manag Care; 2011 Sep; 17(9):e365-74. PubMed ID: 21902444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of bimatoprost 0.03% versus the fixed-combination of latanoprost 0.005% and timolol 0.5% in adult patients with elevated intraocular pressure: an eight-week, randomized, open-label trial.
    Facio AC; Reis AS; Vidal KS; de Moraes CG; Suzuki R; Hatanaka M; Susanna R
    J Ocul Pharmacol Ther; 2009 Oct; 25(5):447-51. PubMed ID: 19860553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Topical Prostaglandin F2α Analogs on Selected Oxidative Stress Parameters in the Tear Film.
    Sedlak L; Zych M; Wojnar W; Wyględowska-Promieńska D
    Medicina (Kaunas); 2019 Jul; 55(7):. PubMed ID: 31336766
    [No Abstract]   [Full Text] [Related]  

  • 16. Latanoprost 0.005% versus bimatoprost 0.03% in primary open-angle glaucoma patients.
    Konstas AG; Katsimbris JM; Lallos N; Boukaras GP; Jenkins JN; Stewart WC
    Ophthalmology; 2005 Feb; 112(2):262-6. PubMed ID: 15691561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of the combination of bimatoprost and latanoprost on intraocular pressure in primary open angle glaucoma: a randomised clinical trial.
    Doi LM; Melo LA; Prata JA
    Br J Ophthalmol; 2005 May; 89(5):547-9. PubMed ID: 15834081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Feasibility and efficacy of a mass switch from latanoprost to bimatoprost in glaucoma patients in a prepaid Health Maintenance Organization.
    Law SK; Song BJ; Fang E; Caprioli J
    Ophthalmology; 2005 Dec; 112(12):2123-30. PubMed ID: 16225924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the effects of latanoprost and bimatoprost on central corneal thickness.
    Sen E; Nalcacioglu P; Yazici A; Aksakal FN; Altinok A; Tuna T; Koklu G
    J Glaucoma; 2008 Aug; 17(5):398-402. PubMed ID: 18703951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MMP expression in leaking filtering blebs and tears after glaucoma filtering surgery.
    Mathalone N; Marmor S; Rahat MA; Lahat N; Oron Y; Geyer O
    Graefes Arch Clin Exp Ophthalmol; 2011 Jul; 249(7):1047-55. PubMed ID: 21452038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.